Exchange: NASDAQ·Updated 08:58 AM EDT
News
all
press releases
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of CVRx, Inc. (CVRx or the Company) (NASDAQ: CVRX) on behalf of investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT...
Business Wire
More News
CVRx, Inc. (CVRX) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of CVRx, Inc. (CVRx or the Company) (NASDAQ: CVRX) investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CVRX, INC. (CVRX), CONTACT THE LAW OFFICES OF HOWARD...
Business Wire
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CVRx, Inc. (CVRx or the Company) (NASDAQ: CVRX) investors concerning the Companys possible violations of the federal securities laws. IF YOU ARE AN...
Business Wire
CVRx Stock Is Falling Overnight: Here's What's Driving the Move
CVRx stock sinks after hours after lowering full-year revenue outlook despite revenue growth.read more...
Benzinga
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
CVRx (CVRX) delivered earnings and revenue surprises of -1.92% and +0.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Compared to Estimates, CVRx (CVRX) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for CVRx (CVRX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0.00% and -4.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?
CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
CVRx CFO Oasheim To Step Down
(RTTNews) - Medical device maker CVRx, Inc. (CVRX) said on Tuesday that its Chief Financial Officer Jared Oasheim will step down to pursue other opportunities, and the company has begun a search for his successor...
Nasdaq News: Markets
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.
Zacks

Advertisement|Remove ads.